Anti-EpCAM CAR-T cells have also been shown to produce robust anti-tumor responses in gastric cancer SNU-638 and MKN-45 and pancreatic Capan2-Fluc+ models in mice, with complete responses maintained in nearly all the mice [106]. Here, EPCAM is linked to neoplasm.